Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells

Tanja Waldmann1, Eugen Rempel, Nina V Balmer

  • 1Doerenkamp-Zbinden Chair for in Vitro Toxicology and Biomedicine, University of Konstanz , 78457 Konstanz, Germany.

Insights

Valproic acid (VPA) concentration impacts human embryonic stem cell development. Identifying the highest non-cytotoxic VPA dose is crucial for accurate toxicogenomics studies in developmental toxicology.

Area of Science:

  • Developmental toxicology
  • Systems biology
  • Transcriptomics

Background:

  • Understanding transcriptome changes at different drug concentrations is vital for developmental toxicology.
  • Valproic acid (VPA) is a drug with known developmental effects.

Purpose of the Study:

  • To investigate the effects of eight VPA concentrations on human embryonic stem cell differentiation to neuroectoderm.
  • To establish design principles for toxicogenomics studies using VPA as a model.

Main Methods:

  • Exposure of human embryonic stem cells to VPA (25-1000 μM) during neuroectodermal differentiation.
  • Transcriptome analysis to identify differentially regulated genes.
  • Biostatistical and systems biology approaches including transcription factor binding site (TFBS) analysis, gene ontology (GO) profiler, and a teratogenicity index.

Main Results:

  • A continuous increase in differentially regulated genes with increasing VPA concentration.
  • Distinct transcriptome signatures differentiating tolerated, teratogenic, and cytotoxic VPA concentrations.
  • Identification of VPA's mode of action signatures (protein acetylation, developmental changes, cell migration) within the teratogenic range.
  • Cytotoxicity associated with catabolism and decreased cell cycle gene expression, not canonical stress indicators.
  • Teratogenicity index effectively distinguished VPA's developmental toxicity from cytotoxicity.

Conclusions:

  • The highest non-cytotoxic drug concentration is recommended for toxicogenomics studies to avoid misleading mode-of-action data.
  • Transcriptome profiling combined with systems biology tools can differentiate drug effects and establish concentration-dependent toxicological principles.

Related Concept Videos